- 24 h
- 7 Tage
- 14 Tage
- 6 Monate
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21:42 | Avicanna Inc: Avicanna unit ships 1st organic CBG flower to Australia | 1 | Stockwatch | ||
| 21:42 | Inhibikase Therapeutics GAAP EPS of -$0.49 | 1 | Seeking Alpha | ||
| 21:42 | LB Pharmaceuticals Inc GAAP EPS of -$0.45 | 1 | Seeking Alpha | ||
| 21:36 | XORTX Therapeutics Inc.: XORTX Announces Change of Effective Date of Share Consolidation | 1 | GlobeNewswire (USA) | ||
| 21:32 | Inhibikase Therapeutics, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 21:32 | LB PHARMACEUTICALS INC - 10-K, Annual Report | 1 | SEC Filings | ||
| 21:30 | Madrigal Pharmaceuticals gains amid renewed takeover speculation | 1 | Seeking Alpha | ||
| 21:22 | Inhibikase Therapeutics, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 21:18 | Shuttle Pharma expands AI drug discovery platform capabilities | 3 | Investing.com | ||
| 21:14 | Shuttle Pharmaceuticals Holdings Inc.: Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows | 177 | Newsfile | Gaithersburg, Maryland--(Newsfile Corp. - March 26, 2026) - Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) ("Shuttle Pharma" or the "Company"), today announced a major advancement to its... ► Artikel lesen | |
| 21:12 | LB Pharmaceuticals Inc: LB Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update | 1 | GlobeNewswire (USA) | ||
| 21:08 | LB PHARMACEUTICALS INC - 8-K, Current Report | 1 | SEC Filings | ||
| 21:06 | Daré Bioscience, Inc.: Daré Bioscience Reports Full Year 2025 Financial Results and Provides Business Update | 2 | GlobeNewswire (USA) | ||
| 21:06 | Dare Bioscience GAAP EPS of -$1.20 beats by $0.45, revenue of $1.03M beats by $0.26M | 1 | Seeking Alpha | ||
| 21:06 | Inhibikase Therapeutics Announces Full Year 2025 Financial Results and Highlights Recent Activity | 1 | GlobeNewswire (USA) | ||
| 21:02 | Dare Bioscience, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 21:01 | Could Buying Eli Lilly Today Set You Up for Life? | 14 | The Motley Fool | ||
| 21:01 | Dare Bioscience, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 20:54 | Leerink cuts Wave Life Sciences stock price target on obesity drug data | 2 | Investing.com | ||
| 20:51 | EQS-News: Dermapharm Holding SE erwirbt im Rahmen ihres öffentlichen Aktienrückkaufangebots 4.299.190 eigene Aktien zurück | 367 | EQS Group (DE) | EQS-News: Dermapharm Holding SE
/ Schlagwort(e): Aktienrückkauf
Dermapharm Holding SE erwirbt im Rahmen ihres öffentlichen Aktienrückkaufangebots 4.299.190 eigene Aktien zurück... ► Artikel lesen |
1 2 3 4 5 Weiter >>
- 24 h
- 7 Tage
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | Aktuelle Nachrichten | |||
|---|---|---|---|---|---|---|---|
| WAVE LIFE SCIENCES | 23 | 2 | -49,07 % | Wave Life Sciences Ltd.: Wave Life Sciences Announces Positive Interim Phase 1 Data from INLIGHT: Further Improvements in Body Composition, with Clinically Meaningful Reductions in Visceral Fat and Waist Circumference, at Six Months Following ... | At 6-month follow-up, a single 240 mg dose of WVE-007 (INHBE GalNAc-siRNA) continued to drive significant placebo-adjusted reductions in visceral fat (-14%; p WVE-007 led to greater improvement in... ► Artikel lesen | ||
 | NOVO NORDISK | 21 | 40 | +0,54 % | Milliardenmarkt vor Umbruch: Angriff auf Eli Lilly und Novo Nordisk: Roche wittert Milliardenchance | © Foto: Udo Herrmann - picture alliance / CHROMORANGERoche will im boomenden Markt für Abnehm-Medikamente wieder angreifen. Der Konzern setzt auf neue Strategien und Milliarden-Deals im Wettbewerb.Der... ► Artikel lesen | |
| MERCK & CO | 9 | 43 | +0,19 % | Kreise: US-Pharmakonzern Merck & Co an Krebsspezialist Terns interessiert | RAHWAY (dpa-AFX) - Der US-Pharmakonzern Merck & Co befindet sich Kreisen zufolge in fortgeschrittenen Verhandlungen über eine Übernahme des Biotechunternehmens Terns Pharmaceuticals. Der Zukauf könnte... ► Artikel lesen | ||
| JIANGSU HENGRUI PHARMACEUTICALS | 7 | - | -2,90 % | Hengrui Pharma Announces Strong 2025 Annual Results | SHANGHAI, March 25, 2026 /PRNewswire/ -- On March 25, 2026, Hengrui Pharma (600276.SH; 01276.HK) announced robust financial results for the full year 2025, fueled... ► Artikel lesen | ||
| BAYER | 6 | 36 | +0,38 % | EQS-News: Formycon AG: Formycon sichert Vermarktungsstart für Aflibercept-2mg-Biosimilar FYB203 in Europa und weiteren Territorien durch Settlement mit Regeneron und Bayer | EQS-News: Formycon AG
/ Schlagwort(e): Sonstiges
Formycon sichert Vermarktungsstart für Aflibercept-2mg-Biosimilar FYB203 in Europa und weiteren Territorien durch Settlement mit... ► Artikel lesen | ||
| OXFORD BIOMEDICA | 6 | - | -2,17 % | Oxford Biomedica FY 2025 slides: CDMO turns profitable on 33% revenue surge | |||
| MEDICUS PHARMA | 5 | 12 | -6,90 % | Medicus Pharma Ltd: Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan | PHILADELPHIA, March 26, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs... ► Artikel lesen | ||
| TILRAY BRANDS | 5 | 7 | -4,36 % | Panik vor Kursbeben: Das Zittern beginnt: Reißen die Tilray-Zahlen Canopy, Aurora & Co in die Tiefe? | © Foto: adobe.stock.comIn Kürze ist es soweit - Tilray wird frische Quartalszahlen vorlegen. Den Tilray-Zahlen kann man dabei durchaus richtungsweisenden Charakter zubilligen. Entsprechend dürften sie... ► Artikel lesen | ||
| LIGAND PHARMACEUTICALS | 5 | 2 | +0,56 % | Ligand Pharmaceuticals: Ligand Advances Strategic Growth with Expanded and Strengthened Business Development Team | JUPITER, Fla., March 26, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced it has appointed two leading healthcare investors, Peter Renehan, MD, and Lee Brown... ► Artikel lesen | ||
| IONIS PHARMACEUTICALS | 5 | - | +2,45 % | Ionis Pharmaceuticals Repriced Drug Ahead Of Key FDA Decision Signals Push Into Larger Market |
- Alle
| Unternehmen / Aktien | Aktueller Kurs | Ø Kursziel (Euro) | Potential (Euro) | kaufen | halten | verkaufen | |||
|---|---|---|---|---|---|---|---|---|---|
| DOCMORRIS AG | 4,600 | 7,37 | +60 % | 6 | 9 | 4 | |||
| SCHOTT PHARMA AG & CO KGAA | 13,500 | 18,70 | +39 % | 3 | 10 | - | |||
| MERCK KGAA | 106,75 | 141,60 | +33 % | 12 | 8 | - | |||
| ELI LILLY AND COMPANY | 780,40 | 968,78 | +24 % | 1 | - | - | |||
| ASTRAZENECA PLC | 159,00 | 190,61 | +20 % | 20 | 1 | 6 | |||
| NOVO NORDISK A/S | 31,850 | 37,42 | +17 % | 17 | 26 | 3 | ||
| SANOFI SA | 81,21 | 94,57 | +16 % | 12 | 16 | - | |||
| BAYER AG | 38,275 | 41,71 | +9 % | 26 | 11 | 1 | |||
| NOVARTIS AG | 129,10 | 129,55 | +0 % | 6 | 13 | 3 | |||
| PFIZER INC | 23,960 | 23,93 | 0 % | 1 | 5 | - | |||
| GSK PLC | 23,660 | 23,51 | -1 % | 4 | 11 | 14 | |||
| DERMAPHARM HOLDING SE | 44,500 | 34 | -24 % | - | 1 | - |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.